Literature DB >> 3502167

Immunomodulatory and therapeutic properties of alkyl lysophospholipids in mice.

J E Talmadge1, M Schneider, B Lenz, H Phillips, C Long.   

Abstract

This paper describes the immunomodulatory and therapeutic properties of the alkyl lysophospholipids [ALP; 1-O-octadecyl-2-O-rac-glycero-3-phosphocholine (ET-18-OCH3)]. ALP was able to activate macrophages both in vitro and in vivo as well as to act as an immunoadjuvant for syngeneic tumor vaccines. However, ALP appeared to be transferred, at least in part, to the macrophage membrane, and some of the tumoricidal macrophage-activating properties seem to be associated with the direct cytotoxic effect of membrane-released ALP. ALP also had some therapeutic activity for experimental and spontaneous metastases, requiring administration three but not two times weekly at near-toxic doses; this suggests that at least some of its therapeutic activity is due to direct cytotoxicity.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3502167     DOI: 10.1007/BF02535547

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  30 in total

1.  A transplantable mast-cell neoplasm in the mouse.

Authors:  T B DUNN; M POTTER
Journal:  J Natl Cancer Inst       Date:  1957-04       Impact factor: 13.506

2.  Primary antibody formation in vitro by mouse cells in a complete homologous system.

Authors:  P G Munder; M Modolell; W Raetz; G A Luckenbach
Journal:  Eur J Immunol       Date:  1973-07       Impact factor: 5.532

3.  The selection and characterization of an invasive variant of the B16 melanoma.

Authors:  I R Hart
Journal:  Am J Pathol       Date:  1979-12       Impact factor: 4.307

4.  The influence of various adjuvants on the metabolism of phospholipids in macrophages.

Authors:  P G Munder; E Ferber; M Modolell; H Fischer
Journal:  Int Arch Allergy Appl Immunol       Date:  1969

Review 5.  Anti-tumor action of alkyl-lysophospholipids (Review).

Authors:  W E Berdel; W R Bausert; U Fink; J Rastetter; P G Munder
Journal:  Anticancer Res       Date:  1981       Impact factor: 2.480

6.  Influence of the alkyllysophospholipid ET-18-OCH3 on methylnitrosourea-induced rat mammary carcinomas.

Authors:  M R Berger; P G Munder; D Schmähl; O Westphal
Journal:  Oncology       Date:  1984       Impact factor: 2.935

7.  Destruction of human solid tumors by alkyl lysophospholipids.

Authors:  M H Runge; R Andreesen; A Pfleiderer; P G Munder
Journal:  J Natl Cancer Inst       Date:  1980-06       Impact factor: 13.506

8.  Distribution and metabolism of synthetic alkyl analogs of lysophosphatidylcholine in mice.

Authors:  B Arnold; R Reuther; H U Weltzien
Journal:  Biochim Biophys Acta       Date:  1978-07-25

9.  Induction of differentiation of cultured human and mouse myeloid leukemia cells by alkyl-lysophospholipids.

Authors:  Y Honma; T Kasukabe; M Hozumi; S Tsushima; H Nomura
Journal:  Cancer Res       Date:  1981-08       Impact factor: 12.701

10.  Antiinvasive effect of racemic 1-O-octadecyl-2-O-methylglycero-3-phosphocholine on MO4 mouse fibrosarcoma cells in vitro.

Authors:  G A Storme; W E Berdel; W J van Blitterswijk; E A Bruyneel; G K De Bruyne; M M Mareel
Journal:  Cancer Res       Date:  1985-01       Impact factor: 12.701

View more
  6 in total

1.  Superoxide production by macrophages stimulated in vivo with synthetic ether lipids.

Authors:  B M Schreiber; M D Layne; E J Modest
Journal:  Lipids       Date:  1994-04       Impact factor: 1.880

2.  Investigation into the immunological effects of miltefosine, a new anticancer agent under development.

Authors:  P Hilgard; E Kampherm; L Nolan; J Pohl; T Reissmann
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

3.  Antitumor activity of Ilmofosine (BM 41.440) in the 3Lewis-lung carcinoma model.

Authors:  D B Herrmann; H G Opitz; P G Munder
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

Review 4.  Membrane-interactive lipids as experimental anticancer drugs.

Authors:  W E Berdel
Journal:  Br J Cancer       Date:  1991-08       Impact factor: 7.640

5.  Evaluation of in vitro and in vivo anti-inflammatory activity of biologically active phospholipids with anti-neoplastic potential in porcine model.

Authors:  Monika Vicenova; Katerina Nechvatalova; Katarina Chlebova; Zdenka Kucerova; Lenka Leva; Hana Stepanova; Martin Faldyna
Journal:  BMC Complement Altern Med       Date:  2014-09-19       Impact factor: 3.659

6.  Growth arrest vs direct cytotoxicity and the importance of molecular structure for the in vitro anti-tumour activity of ether lipids.

Authors:  M Lohmeyer; P Workman
Journal:  Br J Cancer       Date:  1995-08       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.